Position in AZN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,879,569
+$61,493 QoQ
Shares Held
15,186
+6.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#467
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEVEL FOUR ADVISORY SERVICES, LLC holds $97,082,688 across 12 Drug Manufacturers - General names. AZN ranks #8 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
135,146 | $34,008,139 | |
| 2 | JNJ |
Johnson & Johnson
|
65,905 | $16,737,892 | |
| 3 | NVO |
Novo Nordisk A S
|
197,413 | $9,463,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
73,273 | $9,415,580 | |
| 5 | LLY |
ELI LILLY & Co
|
7,377 | $8,848,195 | |
| 6 | AMGN |
Amgen Inc
|
15,638 | $5,662,832 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
31,194 | $3,941,049 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
15,186 | $2,879,569 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,879,569 | 15,186 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,818,076 | 14,289 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||